Standard BioTools Financial Health
How is Standard BioTools's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: LAB's short term assets ($229.0M) exceed its short term liabilities ($46.2M).
Long Term Liabilities: LAB's short term assets ($229.0M) exceed its long term liabilities ($120.2M).
Debt to Equity History and Analysis
Debt Level: LAB has more cash than its total debt.
Reducing Debt: LAB's debt to equity ratio has reduced from 500.7% to 26% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LAB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LAB has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 10.3% each year.